Stochastic Events Regulating a Notch-Mediated Cell Fate Decision in Caenorhabditis elegans
随机事件调节秀丽隐杆线虫介导的细胞命运决定
基本信息
- 批准号:8907446
- 负责人:
- 金额:$ 5.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptedAdultAffectAllelesAnimalsBacteriaBiologicalBirth OrderC. elegans genomeCaenorhabditis elegansCancer EtiologyCell Cycle ProgressionCell Cycle StageCellsDecision MakingDefectDevelopmentDevelopmental BiologyDevelopmental ProcessDrosophila genusEmbryoEventFamily memberFeedbackFertilityFluorescent in Situ HybridizationGenerationsGenesGeneticGenetic ScreeningGenetic TranscriptionGenome engineeringGoalsGonadal structureHumanImageLateralLigandsLobular NeoplasiaMalignant NeoplasmsMeasuresMediatingMethodsMicrofluidicsMolecular GeneticsMotor NeuronsNatureNotch Signaling PathwayOncogenesProcessQuantitative MicroscopyRNA InterferenceRegulationReporterResearchRetinalSignal TransductionSisterSpinal CordTechnologyTestingTimeTo specifyTumor Suppressor Proteinscell fate specificationcell typeeggfascinategranulysinhuman diseaseimprovedin vivomRNA Expressionnotch proteinnovelnovel therapeutic interventionprecursor cellprotein expressionpublic health relevancereceptorsingle moleculetooltumor progressiontumorigenesis
项目摘要
DESCRIPTION (provided by applicant): This proposal is concerned with how stochastic, initial differences arise in the activity of Notch, which must be properly regulated in development and which, when aberrantly regulated, causes cancer. Stochastic events are utilized from bacteria to humans to mediate myriad developmental processes including cell-fate switching and the generation of cell type diversity. Understanding how stochastic events influence cell fate specification is important to understand how reproducible cell fates are generated from groups of equivalent cells during development. The paradigmatic anchor cell (AC)/ventral uterine (VU) cell fate decision in Caenorhabditis elegans incorporates a stochastic mechanism as part of the process by which initially equivalent cells acquire different fates. The two cells undergoing the AC/VU decision each have the potential to become either an AC or a VU. They interact with each other, mediated by LIN-12/Notch, such that only one becomes the AC and one becomes the VU. During the course of the decision, a stochastic event causes these cells, which initially express both the transmembrane receptor LIN-12/Notch and the transmembrane ligand LAG-2 (a Delta/Serrate/LAG-2 family member), to engage feedback mechanisms that restrict transcription of lin-12 to the presumptive VU and lag-2 to the presumptive AC. The goal of this research is to understand how small, early differences in Notch activity are generated between initially equivalent cells. Birth-order of the AC and VU precursors, a random event, is highly correlated with the subsequent cell fate, suggesting that there is a relationship between cell-cycle progression, Notch signaling, and cell fate specification in the AC/VU decision. Here, we will study this relationship to probe the nature of the stochastic cellular events leading to the specification of the AC and VU by combining the powerful genetics of C. elegans with recent advances in C. elegans genome engineering and in vivo fluorescent imaging. First, we will test whether birth-order of the AC and VU precursors creates or reflects a difference between them by genetically manipulating birth-order and lin-12/Notch level. Second, we will quantify lin-12/Notch expression and activation during the AC/VU decision. We will quantify endogenous lin-12/Notch mRNA and protein expression and develop a novel reporter for lin-12/Notch activity. Third, we will conduct genetic screens to identify novel regulators that control Notch activation i the AC/VU decision and their sister cells by directly imaging the somatic gonad at high magnification. In addition to addressing a central question in developmental biology, studies of Notch-mediated cell fate decisions are highly relevant to cancer: Notch can be an oncogene or tumor suppressor depending on cell context, and studies of how Notch activity is regulated in this cell fate paradigm in C. elegans have identified genes involved in tumorigenesis. Furthermore, illuminating the potential intersection between Notch activity, cell cycle progression, and cell fate specification may suggest novel therapeutic approaches.
描述(由申请人提供):该提案涉及Notch活性如何产生随机的、初始的差异,它必须在发育过程中得到适当的调节,并且当调节异常时,会导致从细菌到人类的随机事件。介导无数的发育过程,包括细胞命运转换和细胞类型多样性的产生,了解随机事件如何影响细胞命运规范对于理解发育过程中等效细胞群如何产生可重复的细胞命运非常重要。秀丽隐杆线虫中的范式锚细胞 (AC)/腹侧子宫 (VU) 细胞命运决定纳入了随机机制,作为最初相同细胞获得不同命运的过程的一部分,经历 AC/VU 决定的两个细胞都有可能获得不同的命运。它们通过 LIN-12/Notch 相互交互,使得只有一个成为 AC,一个成为 VU。随机事件导致这些最初表达跨膜受体 LIN-12/Notch 和跨膜配体 LAG-2(Delta/Serrate/LAG-2 家族成员)的细胞参与反馈机制,限制 lin-12 的转录假定的 VU 和 lag-2 与假定的 AC 的关系 本研究的目的是了解最初相同出生顺序的 AC 细胞之间的 Notch 活性有多么微小的早期差异。 VU前体是一个随机事件,与随后的细胞命运高度相关,这表明AC/VU决策中细胞周期进程、Notch信号传导和细胞命运规范之间存在关系。通过将线虫强大的遗传学与线虫基因组工程和体内荧光成像的最新进展相结合,探究导致 AC 和 VU 规范的随机细胞事件的本质。 AC 的顺序和 VU 前体通过遗传操纵出生顺序和 lin-12/Notch 水平来创建或反映它们之间的差异 其次,我们将量化 AC/VU 决策过程中的 lin-12/Notch 表达和激活。 12/Notch mRNA 和蛋白质表达,并开发 lin-12/Notch 活性的新型报告基因。 第三,我们将进行遗传筛选,以确定控制 AC/VU 决策及其姐妹细胞中 Notch 激活的新型调节因子。在高倍率下直接对体细胞性腺进行成像除了解决发育生物学中的一个核心问题外,Notch 介导的细胞命运决定的研究与癌症高度相关:Notch 可以是癌基因或肿瘤抑制基因,具体取决于细胞环境,并且研究秀丽隐杆线虫的细胞命运范式中Notch活性如何受到调节,并且已经鉴定出参与肿瘤发生的基因。此外,阐明Notch活性、细胞周期进程和细胞命运规范之间的潜在交叉可能会提出新的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michelle Andrea Attner其他文献
Michelle Andrea Attner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
中性粒细胞胞外诱捕网(NETs)通过AIM2炎症小体促进成人斯蒂尔病髓系细胞生成并放大细胞因子风暴的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DDX11突变通过激活P38MAPK/PI3K/Akt/CREB信号通路调控钙调蛋白结合蛋白促进成人AML复发的作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多溴联苯醚通过肠道菌群诱导维汉成人2型糖尿病的发生及抗氧化膳食模式的拮抗作用研究
- 批准号:82160605
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
I型干扰素通过下调FOXO3介导NLRC4/NLRP3激活触发成人Still病炎症风暴的研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
Optimization of electromechanical monitoring of engineered heart tissues
工程心脏组织机电监测的优化
- 批准号:
10673513 - 财政年份:2023
- 资助金额:
$ 5.42万 - 项目类别:
The RaDIANT Health Systems Intervention for Equity in Kidney Transplantation
Radiant 卫生系统干预肾移植的公平性
- 批准号:
10681998 - 财政年份:2023
- 资助金额:
$ 5.42万 - 项目类别:
Regulation of human tendon development and regeneration
人体肌腱发育和再生的调节
- 批准号:
10681951 - 财政年份:2023
- 资助金额:
$ 5.42万 - 项目类别:
Toward Accurate Cardiovascular Disease Prediction in Hispanics/Latinos: Modeling Risk and Resilience Factors
实现西班牙裔/拉丁裔的准确心血管疾病预测:风险和弹性因素建模
- 批准号:
10852318 - 财政年份:2023
- 资助金额:
$ 5.42万 - 项目类别:
The impact of Medicaid expansion on the rural mortality penalty in the United States
医疗补助扩大对美国农村死亡率的影响
- 批准号:
10726695 - 财政年份:2023
- 资助金额:
$ 5.42万 - 项目类别: